CORFLOW

Firm aims to introduce to the market a new generation coronary shunt for use during coronary artery bypass grafting surgery (CABG). CorFlow technology is being developed with several technological innovations increasing safety for the patients and facilitating shunt use by cardiac surgeons. Next generation coronary shunt is dedicated to improve the results of coronary artery bypass grafting and expand global number of less invasive CABG technique – beating heart, off-pump coronary artery bypass grafting (OPCAB). Firm is conducted by physicians, including cardiac surgeon, specialists in medical devices designing, engineers, specialist of computational fluid dynamic modeling and managers experienced in med-tech sector and technology transfer to global markets.